Browsing: Magazine

The U.S. Food and Drug Administration (FDA) has updated its medical device recall list to include some GE HealthCare Omni Legend systems citing the chance for the devices to create artifacts during PET exams. These artifacts pose the risk of impacting the ability to properly read and assess images.

Artificial intelligence (AI) chatbots in healthcare top the 2026 list of the most significant health technology hazards. The report is prepared annually by ECRI, an independent, nonpartisan patient safety organization.

The ASRT Foundation Scholarship Review Committee has selected ASRT member, Elyse Starr, a radiography student at Indiana University South Bend, as the recipient of the Weber State University School of Radiologic Sciences Student Global Engagement Scholarship.

The only industry event dedicated exclusively to imaging directors, radiology administrators, radiologic technologists and imaging engineers from hospital departments, freestanding imaging centers and group practices.

The HITRUST e1 Certification verifies that the CIVIE ecosystem, comprised of a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-powered Radiology Dictation Solution (ASR), Revenue Cycle Management (RCM), and Vendor Neutral Archives (VNA), has met criteria defined by leading cybersecurity and regulatory frameworks, with strong controls in place to protect sensitive data and manage information risk effectively.

Joint Commission has opened the application period for the 2026 John M. Eisenberg Patient Safety and Quality Awards, presented in partnership with the National Quality Forum (NQF), and the 2026 Bernard J. Tyson Award for Pursuit of Healthcare Equity, presented in partnership with Kaiser Permanente.

Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, has highlighted the publication of a peer-reviewed clinical study in CHEST. The study demonstrates that structural and functional pulmonary MRI adds important new insights in predicting pulmonary exacerbations beyond standard pulmonary function tests in people living with cystic fibrosis (CF).